赛隆药业集团股份有限公司关于召开2026年第三次临时股东会的通知

Group 1 - The company, Sailong Pharmaceutical Group Co., Ltd., will hold its third extraordinary general meeting of shareholders on March 5, 2026, in Changsha, Hunan Province, combining on-site and online voting [1][3][4] - The meeting will be convened by the company's board of directors and has been approved in a previous board meeting, ensuring compliance with relevant laws and regulations [2][9] - Shareholders must register by March 2, 2026, to attend the meeting, and they can delegate representatives to vote on their behalf [5][11] Group 2 - The company has appointed Yongxin Ruihe (Shenzhen) CPA Firm as the new auditor for the 2025 financial report and internal control audit, replacing the previous auditor due to workload and personnel changes [22][23][24] - The new auditor has a solid background, with 36 partners and 160 registered accountants, and has provided audit services to listed companies [24][25] - The appointment of the new auditor has been approved by the company's board and will be submitted for shareholder approval [36][38]